Literature DB >> 9539652

Postprandial cholecystokinin response in patients with chronic pancreatitis in treatment with oral substitutive pancreatic enzymes.

M C Garcés1, J Gómez-Cerezo, R Codoceo, C Grande, J Barbado, J J Vázquez.   

Abstract

Cholecystokinin (CCK) response to a test meal should be increased in patients with pancreatic insufficiency, as trypsin is absent from the duodenum. If pancreatic enzymes are added, a restoration of the inhibitory feedback should result in lower levels of CCK. Ten patients with chronic pancreatitis and steatorrhea were studied. CCK basal and postprandial levels were evaluated the day before and 45 and 90 days after treatment with oral pancreatin. Twelve healthy volunteers were included as reference group. CCK basal levels did not vary. CCK response to a test meal was increased in patients before treatment and diminished when oral enzymes were maintained for months even after three days of therapy withdrawal. We conclude that long-term therapy with oral enzymes induces changes in CCK response that do not regress after three days of treatment suspension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539652     DOI: 10.1023/a:1018815225100

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).

Authors:  S Domschke; S R Bloom; T E Adrian; G Lux; W Domschke
Journal:  Hepatogastroenterology       Date:  1988-10

2.  Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis.

Authors:  P Cantor; L Petronijevic; H Worning
Journal:  Pancreas       Date:  1986       Impact factor: 3.327

3.  Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis.

Authors:  W H Nealon; R D Beauchamp; C M Townsend; G Boyd; M Shabot; J C Thompson
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

4.  Inhibitor-stimulated non-parallel pancreatic secretion in man: hormonal and neural regulation?

Authors:  J E Reseland; H Holm; T Jenssen; M B Jacobsen; L E Hanssen
Journal:  Scand J Gastroenterol       Date:  1995-01       Impact factor: 2.423

5.  Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex.

Authors:  C Owyang; D May; D S Louie
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

6.  Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.

Authors:  P Layer; J B Jansen; L Cherian; C B Lamers; H Goebell
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

7.  Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion.

Authors:  J E Reseland; H Holm; M B Jacobsen; T G Jenssen; L E Hanssen
Journal:  J Nutr       Date:  1996-03       Impact factor: 4.798

8.  Influence of treatment with pancreatic extracts on pancreatic enzyme secretion.

Authors:  J Mössner; H P Wresky; W Kestel; J Zeeh; U Regner; W Fischbach
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

9.  Feedback regulation of stimulated pancreatic enzyme secretion during intraduodenal perfusion of trypsin in man.

Authors:  J Długosz; U R Fölsch; A Czajkowski; A Gabryelewicz
Journal:  Eur J Clin Invest       Date:  1988-06       Impact factor: 4.686

10.  Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.

Authors:  G Adler; M Reinshagen; I Koop; B Göke; A Schafmayer; L C Rovati; R Arnold
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

View more
  1 in total

Review 1.  The Pancreas: Causes for Malabsorption.

Authors:  Thilo Hackert; Kerstin Schütte; Peter Malfertheiner
Journal:  Viszeralmedizin       Date:  2014-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.